MedPath

Embryo Development Using Two Commercial Single-step Media

Not Applicable
Completed
Conditions
Infertility
Registration Number
NCT02302638
Lead Sponsor
Eugonia
Brief Summary

This prospective study with sibling oocytes will evaluate the efficiency of two commercial single-step media, namely Sage 1-step and Continuous Single Culture Medium (CSCM), in terms of embryo utilization rates, blastocyst formation rates, embryo quality and pregnancy rates. Embryos will be cultured continuously for up to 6 days under identical conditions.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
43
Inclusion Criteria
  • at least 10 oocytes retrieved
Exclusion Criteria
  • frozen oocytes
  • testicular biopsy
  • less than 10 oocytes retrieved
  • older than 40 years

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Utilization rates6 days post oocyte retrieval

Utilization = embryos selected for transfer and cryopreservation

Blastocyst formation5 days post oocyte retrieval

Number of blastocysts on day 5 post oocyte retrieval per fertilized oocytes

Secondary Outcome Measures
NameTimeMethod
Embryo quality on day 33 days post oocyte retrieval
blastocyst quality on day 55 days post oocyte retrieval
positive pregnancy test15 days post oocyte retrieval
clinical pregnancy7 weeks of gestation

presence of gestational sac with positive fetal heartbeat

Trial Locations

Locations (1)

Eugonia Assisted Reproduction Unit

🇬🇷

Athens, Attica, Greece

Eugonia Assisted Reproduction Unit
🇬🇷Athens, Attica, Greece

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.